Jalindar Dagadu Padwal

Jalindar Dagadu Padwal

Active Director Director DIN 07397538
DIN 07397538 First appointment Jan 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Jan 2016
Shareholding value •••• Premium profile

About Jalindar Dagadu Padwal

Data last updated:

Jalindar Dagadu Padwal is a Director at Atharva Biopharma Private Limited (since 2019), Designated Partner at Aes Pharma Llp (since 2026) and Director at Bioquant Pharmaceuticals Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma. The largest current company by reported revenue is Atharva Biopharma Private Limited at ₹7.23 Cr (FY 2025). Earlier, Jalindar Dagadu Padwal was a Director at Atharva Biopharma And Research Private Limited (from 2019) and Director at Nova Beverages Private Limited (from 2016).

DIN 07397538
Primary Designation Director
Industry Pharma
First Appointment 07 Jan 2016
Oldest Company Age 10 yrs
Largest company Atharva Biopharma Private Limited · ₹7.23 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Atharva Biopharma Private Limited U24304PN2019PTC187991
Director25 Nov 20192019₹7.23 Cr (FY 2025)Active
Aes Pharma Llp ADC-4625
Designated Partner21 Sep 20262026Active
Director23 Dec 20252025Active
Director20 Mar 20172017Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Jul 20192019Strike Off
Nova Beverages Private Limited U74990PN2016PTC157872
Director07 Jan 20162016Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Neowise Life Sciences Private Limited
Atharva Biopharma And Research Private Limited
Atharva Biopharma Private Limited
Nova Beverages Private Limited
Premium access

Shareholding and investment profile for Jalindar Dagadu Padwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jalindar Dagadu Padwal

Jalindar Dagadu Padwal currently holds 4 directorships: Atharva Biopharma Private Limited (Director, since 25 Nov 2019, revenue ₹7.23 Cr (FY 2025)); Aes Pharma Llp (Designated Partner, since 21 Sep 2026); Bioquant Pharmaceuticals Private Limited (Director, since 23 Dec 2025); Neowise Life Sciences Private Limited (Director, since 20 Mar 2017).

Jalindar Dagadu Padwal was first appointed on 07 Jan 2016 as Director at Nova Beverages Private Limited. The most recent appointment on record is 21 Sep 2026 at Aes Pharma Llp.

Jalindar Dagadu Padwal held 2 earlier board appointments: Atharva Biopharma And Research Private Limited (Director, from 18 Jul 2019); Nova Beverages Private Limited (Director, from 07 Jan 2016).

The current boards of Jalindar Dagadu Padwal's companies include Mansing Nanasaheb Pachundkar (Atharva Biopharma Private Limited), Mohan Raghunath Jadhav (Atharva Biopharma Private Limited), Sanjaykumar Harishchandra Mache (Atharva Biopharma Private Limited), Sharad Raosaheb Sable (Aes Pharma Llp), Niketan Fakkad Shete (Bioquant Pharmaceuticals Private Limited), Ankush Ramchandra Kshirsagar (Neowise Life Sciences Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available